6-Fluoro-1-methyl-4-oxo-7-(1-piperazinyl)-1,4-dihydro-3-quinolinecarboxylic acid(CAS: 70459-07-3)

This compound should comply with the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), REACH regulations for the European Union, and FDA/EPA guidelines for use in pharmaceuticals and environmental emissions. Specific handling, storage, and disposal regulations may vary by country or application.

Alternative reagents such as 6-chloro-1-methyl-4-oxo-7-(1-piperazinyl)-1,4-dihydro-3-quinolinecarboxylic acid and related quinoline derivatives can be considered as substitutes. Isomers like 1-ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydro-3-quinolinecarboxylic acid may also be viable alternatives, depending on the specific application.

The market for this compound shows increasing interest in its use as an intermediate in the development of new pharmaceuticals, particularly in antipsychotic drugs. Research trends indicate a focus on its pharmacological activities and potential in treating neurological disorders. Market trends suggest growing demand, driven by advancements in drug discovery and clinical applications.

Waste containing this compound should be collected in appropriate containers and disposed of through professional waste disposal services that comply with local regulations. Environmental protection measures include proper incineration or chemical treatment to ensure complete degradation and minimal environmental impact. Always consult with environmental safety experts and regulatory bodies for specific disposal guidelines.